menu-iconMore mobile-close-icon
Skip Navigation
Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-4 of 4  
 
1.  
British HIV Association guidelines for HIV-associated malignancies 2014. 2008 (revised 2014 Mar). NGC:010275
British HIV Association - Disease Specific Society. View all guidelines by the developer(s)
2.  
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. 2013 Jun. NGC:009787
Association for Molecular Pathology - Medical Specialty Society; College of American Pathologists - Medical Specialty Society; International Association for the Study of Lung Cancer - Disease Specific Society. View all guidelines by the developer(s)
3.  
Advanced breast cancer. Diagnosis and treatment. 2003 May (revised 2009 Feb). NGC:007179
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. 2007 Jan 1 (revised 2013 Nov 1). NGC:010054
American Society of Clinical Oncology - Medical Specialty Society; College of American Pathologists - Medical Specialty Society. View all guidelines by the developer(s)
1-4 of 4